Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adherence to topical therapies in actinic keratosis: A literature review
Peter Foley, Eggert Stockfleth, Ketty Peris, et al.
Journal of Dermatological Treatment (2016) Vol. 27, Iss. 6, pp. 538-545
Closed Access | Times Cited: 23

Showing 23 citing articles:

Pharmacokinetics, Safety, and Tolerability of a Single 5‐Day Treatment of Tirbanibulin Ointment 1% in 100 cm2: A Phase 1 Maximal‐Use Trial in Patients with Actinic Keratosis
Janet DuBois, Terry M. Jones, Mark S. Lee, et al.
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 2, pp. 208-218
Open Access | Times Cited: 4
Pre-treatment with topical 5-fluorouracil increases the efficacy of daylight photodynamic therapy for actinic keratoses – a randomized controlled trial
Stine Regin Wiegell, Gabriella Fredman, F. Alan Andersen, et al.
Photodiagnosis and Photodynamic Therapy (2024) Vol. 46, pp. 104069-104069
Open Access | Times Cited: 4
Discrepancy Between Patient‐Reported and Physician‐Prescribed Chemoprevention in Patients With Keratinocyte Carcinomas
E A Fagan, Joseph McGrath, Kaeli Samson, et al.
International Journal of Dermatology (2025)
Open Access
Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice
Miguel Mansilla‐Polo, Carlos Abril‐Pérez, Daniel Martín‐Torregrosa, et al.
Australasian Journal of Dermatology (2023) Vol. 64, Iss. 4, pp. 560-564
Closed Access | Times Cited: 6
Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update
Spencer M. Vale, Dane Hill, Steven R. Feldman
PharmacoEconomics (2016) Vol. 35, Iss. 2, pp. 177-190
Closed Access | Times Cited: 15
Patient-reported outcomes in topical field treatment of actinic keratosis in Swedish and Danish patients
Hanna Norrlid, Jenny M. Norlin, Heidi Holmstrup, et al.
Journal of Dermatological Treatment (2017) Vol. 29, Iss. 1, pp. 68-73
Open Access | Times Cited: 16
Use of complete clearance for assessing treatment efficacy for 5-fluorouracil interventions in actinic keratoses: how baseline lesion count can impact this outcome
Khaled Ezzedine, C. Painchault, Mélanie Brignone
Journal of Market Access & Health Policy (2020) Vol. 8, Iss. 1, pp. 1829884-1829884
Open Access | Times Cited: 12
Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report
J.Q. Del Rosso, April W. Armstrong, Brian Berman, et al.
Journal of Drugs in Dermatology (2021) Vol. 20, Iss. 8, pp. 888-893
Open Access | Times Cited: 8
Poor Adherence to Self-Applied Topical Drug Treatment Is a Common Source of Low Lesion Clearance in Patients with Actinic Keratosis—A Cross-Sectional Study
Elias A. T. Koch, Theresa Steeb, Sophia Bender-Säbelkampf, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3813-3813
Open Access | Times Cited: 3
The Importance of Medication Adherence in the Treatment of Actinic Keratosis: An Expert Consensus Panel
Danny Zakria, April W. Armstrong, Brian Berman, et al.
SKIN The Journal of Cutaneous Medicine (2023) Vol. 7, Iss. 3, pp. 752-763
Open Access | Times Cited: 2
Three-Day Field Treatment with Ingenol Disoxate (LEO 43204) for Actinic Keratosis: Cosmetic Outcomes and Patient Satisfaction from a Phase II Trial.
Brian Berman, Stephen K. Tyring, Walter K. Nahm, et al.
PubMed (2017) Vol. 10, Iss. 11, pp. 26-32
Closed Access | Times Cited: 5
Considerations in the Management of Actinic Keratoses: The Importance of Adherence and Persistence to Therapy
Justin W. Marson, J.Q. Del Rosso, Neal Bhatia, et al.
SKIN The Journal of Cutaneous Medicine (2021) Vol. 5, Iss. 2, pp. 83-89
Open Access | Times Cited: 4
Self-expressed patient preferences for the treatment of actinic keratosis: results from a non-interventional study based on a real-life setting in Spain
Ana Julia García‐Malinis, Tamara Gracia‐Cazaña, Yolanda Gilaberte
European Journal of Dermatology (2018) Vol. 28, Iss. 1, pp. 113-115
Closed Access | Times Cited: 3
Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis, Bowen’s Disease, and Squamous Cell Carcinoma: A Systematic Review
Adam H. Lapidus, Sangho Lee, Zhao Feng Liu, et al.
Journal of Cutaneous Medicine and Surgery (2024) Vol. 28, Iss. 4, pp. 375-380
Closed Access
The role of an education E-module in patient adherence and satisfaction of topical 5-fluorouracil: a pilot study
Bo Kitrell, Sierra Thomas, Adam Sutton
Archives of Dermatological Research (2024) Vol. 316, Iss. 6
Closed Access
Approaches to Field Therapy for Actinic Keratoses: Relating Clinical Trial Results to Real-world Practice-A Commentary.
David M. Pariser
PubMed (2022) Vol. 15, Iss. 4, pp. 40-43
Closed Access | Times Cited: 2
Treatment adherence with diclofenac 3% gel among patients with multiple actinic keratoses: an integrated low-intensity intervention program versus standard-of-care
Francesca Perino, Alice Fattori, Alfredo Piccerillo, et al.
Italian Journal of Dermatology and Venereology (2021) Vol. 157, Iss. 2
Closed Access | Times Cited: 2
Field treatment of actinic keratosis on the scalp
Chris Bower
British Journal of Dermatology (2017) Vol. 176, Iss. 6, pp. 1425-1426
Closed Access | Times Cited: 1
Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp
Eggert Stockfleth, Catherine Α. Harwood, C. Serra‐Guillén, et al.
British Journal of Dermatology (2017) Vol. 178, Iss. 2, pp. 433-442
Closed Access
Non-invasive treatment of epidermal keratinocyte neoplasms
Kessels
(2018)
Open Access
Treatment responder analysis in actinic keratosis: can it lead the way to individualized choice of treatment?
Lutz Schmitz, Jes B. Hansen, Mike Bastian, et al.
Journal of Dermatological Treatment (2019) Vol. 32, Iss. 4, pp. 411-417
Closed Access
Therapeutic Non-Adherence
Stephanie K. Fabbro
Springer eBooks (2021), pp. 113-122
Closed Access
Page 1

Scroll to top